EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances

Phanindra Babu Kasi, Venkata Ramana Mallela iD, Filip Ambrozkiewicz iD, Andriy Trailin iD, Václav Liška, Kari Hemminki iD

International Journal of Molecular Sciences · 27.04.2023 · 24 (9) · 7922

DOI: 10.3390/ijms24097922 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.04.2023. Verfasst von Phanindra Babu Kasi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1665/76, 323 00 Pilse…. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Nanotubes, Carbon, Metal Nanoparticles, Nanoparticles. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union’s Horizon 2020 research and innovation program, Ministry of Health of the Czech Republic AZV, Cooperation Program, research area SURG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is the third most common cancer worldwide, and metastatic CRC is a fatal disease. The CRC-affected tissues show several molecular markers that could be used as a fresh strategy to create newer methods of treating the condition. The liver and the peritoneum are where metastasis occurs most frequently. Once the tumor has metastasized to the liver, peritoneal carcinomatosis is frequently regarded as the disease’s final stage. However, nearly 50% of CRC patients with peritoneal carcinomatosis do not have liver metastases. New diagnostic and therapeutic approaches must be developed due to the disease’s poor response to present treatment choices in advanced stages and the necessity of an accurate diagnosis in the early stages. Many unique and amazing nanomaterials with promise for both diagnosis and treatment may be found in nanotechnology. Numerous nanomaterials and nanoformulations, including carbon nanotubes, dendrimers, liposomes, silica nanoparticles, gold nanoparticles, metal-organic frameworks, core-shell polymeric nano-formulations, and nano-emulsion systems, among others, can be used for targeted anticancer drug delivery and diagnostic purposes in CRC. Theranostic approaches combined with nanomedicine have been proposed as a revolutionary approach to improve CRC detection and treatment. This review highlights recent studies, potential, and challenges for the development of nanoplatforms for the detection and treatment of CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal NeoplasmsNanotubes, CarbonMetal NanoparticlesNanoparticlesColorectal NeoplasmsHumansNanomedicinePrecision MedicineGoldTheranostic NanomedicineDrug Delivery Systems

Stichwörter der Autor:innen

cancer therapyclinical statuscolorectal cancernanomedicinetheranostics

Substanzen

Nanotubes, CarbonGold

Autor:innen und Institutionen

  • Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1665/76, 323 00 Pilsen, Czech Republic.
  • Laboratory of Cancer Treatment and Tissue Regeneration, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1665/76, 323 00 Pilsen, Czech Republic.
  • Department of Surgery, University Hospital in Pilsen and Faculty of Medicine in Pilsen, Charles University, Alej Svobody 80, 323 00 Pilsen, Czech Republic.
  • Department of Cancer Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

ORCID-Profile: Venkata Ramana Mallela, Filip Ambrozkiewicz, Andriy Trailin, Kari Hemminki

Förderung

  • European Union’s Horizon 2020 research and innovation program
  • Ministry of Health of the Czech Republic AZV
  • Cooperation Program, research area SURG
  • National Institute for Cancer Research—NICR

Zitieren

APA

Kasi, P. B., Mallela, V. R., Ambrozkiewicz, F., Trailin, A., Liška, V., & Hemminki, K. (2023). Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances. International Journal of Molecular Sciences, 24(9), 7922. https://doi.org/10.3390/ijms24097922

Vancouver

Kasi PB, Mallela VR, Ambrozkiewicz F, Trailin A, Liška V, Hemminki K. Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances. International Journal of Molecular Sciences. 2023;24(9):7922. doi:10.3390/ijms24097922

BibTeX
@article{Kasi2023,
  author = {Kasi, Phanindra Babu and Mallela, Venkata Ramana and Ambrozkiewicz, Filip and Trailin, Andriy and Liška, Václav and Hemminki, Kari},
  title = {Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {9},
  pages = {7922},
  doi = {10.3390/ijms24097922}
}
Kostenlos starten →